STOCK TITAN

Avenir Wellness Solutions Inc - CURR STOCK NEWS

Welcome to our dedicated news page for Avenir Wellness Solutions (Ticker: CURR), a resource for investors and traders seeking the latest updates and insights on Avenir Wellness Solutions.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Avenir Wellness Solutions's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Avenir Wellness Solutions's position in the market.

Rhea-AI Summary
Avenir Wellness Solutions, Inc. (AVRW) announced encouraging results for the third fiscal quarter of 2023, with net revenue increasing sequentially to $1.0 million. Gross margin expanded by 80 basis points quarter-to-quarter, although it decreased by 740 basis points year-over-year. SG&A expenses decreased by $721 thousand, and the net operating loss improved by $30 thousand. The company's new beauty subscription program and DNA Complex hero product have shown significant growth, and the company regained compliance with the OTCQB Standards.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Avenir Wellness Solutions, Inc. has received regulatory approval to change its ticker symbol from 'CURR' to 'AVRW' effective August 9, 2023. The name change reflects the company's focus on wellness technology and its efforts to create and commercialize quality products and brands in the wellness and beauty space. The company aims to increase revenue with high-margin products and grow its shareholder value through innovative technologies and strategic partnerships.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8%
Tags
none
-
Rhea-AI Summary
Avenir Wellness Solutions, Inc. (OTC:CURR) announced encouraging results for the first quarter of 2023. The company reported a 15.1% year-over-year increase in net revenue, with gross margins improving by 102 basis points to 78.9%. Despite increased SG&A expenses, the net operating loss decreased by $0.5 million. The launch of new products and marketing initiatives are expected to contribute to further revenue growth and high margin sales. Avenir's new product, DNA Complex, received positive coverage from prominent sources after its launch.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.96%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.77%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.14%
Tags
none
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.06%
Tags
none
Avenir Wellness Solutions Inc

OTC:CURR

CURR Rankings

CURR Stock Data

7.85M
48.81M
30.38%
0.27%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States
Sherman Oaks

About CURR

cure pharmaceutical is an innovative drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems. cure has an industry leading full-service cgmp manufacturing facility and is a preeminent developer and manufacturer of a patented and proprietary delivery system (curefilmâ„¢), the most advanced oral thin film on the market today. cure has developed an array of products in cutting-edge delivery platforms and partners with leading pharmaceutical companies. cure has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the u.s., canada, israel and germany, among other markets. our mission is to improve people's lives by redefining how medicines are delivered and experienced.